Evidence map›Paper›PMID 35203721›Full record

ArticleBiomedicines2022

Single Application of Low-Dose, Hydroxyapatite-Bound BMP-2 or GDF-5 Induces Long-Term Bone Formation and Biomechanical Stabilization of a Bone Defect in a Senile Sheep Lumbar Osteopenia Model.

Ines Hasenbein, André Sachse, Peter Hortschansky, Klaus D Schmuck, Victoria Horbert, Christoph Anders, Thomas Lehmann, René Huber, Alexander Maslaris, Frank Layher and 4 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Ines HasenbeinDepartment of Orthopedics, Jena University Hospital, Waldkliniken Eisenberg GmbH, 07607 Eisenberg, Germany.
André SachseDepartment of Orthopedics, Jena University Hospital, Waldkliniken Eisenberg GmbH, 07607 Eisenberg, Germany.
Peter HortschanskyLeibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI), 07745 Jena, Germany.
Klaus D SchmuckJohnson & Johnson Medical GmbH, DePuySynthes, 22851 Norderstedt, Germany.
Victoria HorbertDepartment of Orthopedics, Jena University Hospital, Waldkliniken Eisenberg GmbH, 07607 Eisenberg, Germany.
Christoph AndersDivision of Motor Research, Pathophysiology and Biomechanics, Experimental Trauma Surgery, Department for Hand, Reconstructive, and Trauma Surgery, Jena University Hospital, 07743 Jena, Germany.
Thomas LehmannInstitute of Medical Statistics, Computer Sciences and Data Sciences, Jena University Hospital, 07743 Jena, Germany.
René HuberInstitute of Clinical Chemistry, Hannover Medical School, 30625 Hannover, Germany.ORCID 0000-0002-1041-9935
Alexander MaslarisDepartment of Orthopedics, Jena University Hospital, Waldkliniken Eisenberg GmbH, 07607 Eisenberg, Germany.
Frank LayherDepartment of Orthopedics, Jena University Hospital, Waldkliniken Eisenberg GmbH, 07607 Eisenberg, Germany.ORCID 0000-0002-1427-2213
Christina BraunExperimental Rheumatology Unit, Department of Orthopedics, Jena University Hospital, Waldkliniken Eisenberg GmbH, 07607 Eisenberg, Germany.
Andreas RothBereich Endoprothetik/Orthopädie, Klinik für Orthopädie, Unfallchirurgie und Plastische Chirurgie, Uniklinik Leipzig AöR, 04103 Leipzig, Germany.
Frank PlögerBIOPHARM GmbH, Czernyring 22, 69115 Heidelberg, Germany.
Raimund W KinneExperimental Rheumatology Unit, Department of Orthopedics, Jena University Hospital, Waldkliniken Eisenberg GmbH, 07607 Eisenberg, Germany.ORCID 0000-0002-6104-482X
Waldkrankenhaus Rudolf Elle · DEJena University Hospital · DEJohnson & Johnson (Germany) · DELeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEMedizinische Hochschule Hannover · DER-Biopharm (Germany) · DE

Funding

German Federal Ministry of Education and Research 0313177German Federal Ministry of Education and Research 0316205BGerman Federal Ministry of Education and Research 03577DGerman Federal Ministry of Education and Research 13N12601
6 · The paper itself

Abstract

Effects of hydroxyapatite (HA) particles with bone morphogenetic BMP-2 or GDF-5 were compared in sheep lumbar osteopenia; in vitro release in phosphate-buffered saline (PBS) or sheep serum was assessed by ELISA. Lumbar (L) vertebral bone defects (Ø 3.5 mm) were generated in aged, osteopenic female sheep (

Indexed as

animal modelBMP-2GDF-5growth factorsosteoinductiveosteopeniasheep

Identifiers

PMID35203721
PMCPMC8962316
OpenAlexW4212960787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.